270 related articles for article (PubMed ID: 18562517)
1. Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.
Armitage AE; Katzourakis A; de Oliveira T; Welch JJ; Belshaw R; Bishop KN; Kramer B; McMichael AJ; Rambaut A; Iversen AK
J Virol; 2008 Sep; 82(17):8743-61. PubMed ID: 18562517
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome.
Ebrahimi D; Anwar F; Davenport MP
Retrovirology; 2012 Dec; 9():113. PubMed ID: 23256516
[TBL] [Abstract][Full Text] [Related]
3. Hypermutation of an ancient human retrovirus by APOBEC3G.
Lee YN; Malim MH; Bieniasz PD
J Virol; 2008 Sep; 82(17):8762-70. PubMed ID: 18562521
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.
Armitage AE; Deforche K; Chang CH; Wee E; Kramer B; Welch JJ; Gerstoft J; Fugger L; McMichael A; Rambaut A; Iversen AK
PLoS Genet; 2012; 8(3):e1002550. PubMed ID: 22457633
[TBL] [Abstract][Full Text] [Related]
5. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
6. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
Jin SY; Choi HY; Kim HS; Jung YT
Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
[TBL] [Abstract][Full Text] [Related]
7. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN; Holmes RK; Malim MH
J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya.
Land AM; Ball TB; Luo M; Pilon R; Sandstrom P; Embree JE; Wachihi C; Kimani J; Plummer FA
J Virol; 2008 Aug; 82(16):8172-82. PubMed ID: 18550667
[TBL] [Abstract][Full Text] [Related]
9. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
[TBL] [Abstract][Full Text] [Related]
10. Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals.
Neogi U; Shet A; Sahoo PN; Bontell I; Ekstrand ML; Banerjea AC; Sonnerborg A
J Int AIDS Soc; 2013 Feb; 16(1):18472. PubMed ID: 23443042
[TBL] [Abstract][Full Text] [Related]
11. Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
Jern P; Russell RA; Pathak VK; Coffin JM
PLoS Pathog; 2009 Apr; 5(4):e1000367. PubMed ID: 19343218
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
Liddament MT; Brown WL; Schumacher AJ; Harris RS
Curr Biol; 2004 Aug; 14(15):1385-91. PubMed ID: 15296757
[TBL] [Abstract][Full Text] [Related]
13. APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but APOBEC3G cannot traffic.
Bennett RP; Diner E; Sowden MP; Lees JA; Wedekind JE; Smith HC
Biochem Biophys Res Commun; 2006 Nov; 350(1):214-9. PubMed ID: 16999936
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding.
Bennett RP; Presnyak V; Wedekind JE; Smith HC
J Biol Chem; 2008 Mar; 283(12):7320-7. PubMed ID: 18165230
[TBL] [Abstract][Full Text] [Related]
15. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
Schröfelbauer B; Senger T; Manning G; Landau NR
J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
[TBL] [Abstract][Full Text] [Related]
16. Biased nucleotide composition of the genome of HERV-K related endogenous retroviruses and its evolutionary implications.
Zsíros J; Jebbink MF; Lukashov VV; Voûte PA; Berkhout B
J Mol Evol; 1999 Jan; 48(1):102-11. PubMed ID: 9873082
[TBL] [Abstract][Full Text] [Related]
17. The human endogenous retrovirus family HERV-K(HML-3).
Mayer J; Meese EU
Genomics; 2002 Sep; 80(3):331-43. PubMed ID: 12213204
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo.
Fan J; Ma G; Nosaka K; Tanabe J; Satou Y; Koito A; Wain-Hobson S; Vartanian JP; Matsuoka M
J Virol; 2010 Jul; 84(14):7278-87. PubMed ID: 20463074
[TBL] [Abstract][Full Text] [Related]
19. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
Esnault C; Heidmann O; Delebecque F; Dewannieux M; Ribet D; Hance AJ; Heidmann T; Schwartz O
Nature; 2005 Jan; 433(7024):430-3. PubMed ID: 15674295
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of the two cytidine deaminase domains in APOBEC3G.
Li X; Ma J; Zhang Q; Zhou J; Yin X; Zhai C; You X; Yu L; Guo F; Zhao L; Li Z; Zeng Y; Cen S
Virology; 2011 Jun; 414(2):130-6. PubMed ID: 21489586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
